Skip to main content
Industry News
PET shows promise in diagnosing treatable dementia
9/16/2020

PET with amyloid radiotracers identified 20% to 57% of people with suspected idiopathic normal pressure hydrocephalus, a treatable form of dementia, who had Alzheimer's disease pathology, according to a review in the International Journal of Molecular Sciences. The findings suggest that PET can be used to better understand INPH pathophysiology and improve clinical management of the disease, researchers wrote.

Full Story: